Development and evaluation of magnetic microemulsion: tool for targeted delivery of camptothecin to BALB/c mice-bearing breast cancer

References

• Liu LF, Desai SD, Li TK, et al. Mechanism of action of camptothecin. Ann NY Acad Sci 2000;922:1–10
   PubMed Web of Science ®Google Scholar
• Pizzolato JF, Saltz LB. The camptothecins. Lancet 2003;361:2235–42
   PubMed Web of Science ®Google Scholar
• Tanizawa A, Fujimori A, Fujimori Y, Pommier Y. Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. J Natl Cancer Inst 1994;86:836–42
   PubMed Web of Science ®Google Scholar
• Gao Y, Li LB, Zhai G. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces 2008;64:194–9
   PubMed Web of Science ®Google Scholar
• Fassberg J, Stella VJ. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci 1992;81:676–84
   PubMed Web of Science ®Google Scholar
• Mi Z, Burke TG. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 1994;33:10325–36
   PubMed Web of Science ®Google Scholar
• Burris HA III. Topotecan: incorporating it into the treatment of solid tumors. Oncologist 1998;3:1–3
   PubMedGoogle Scholar
• Rivory LP, Robert J. Molecular, cellular, and clinical aspects of the pharmacology of 20(S) camptothecin and its derivatives. Pharmacol Ther 1995;68:269–96
   PubMed Web of Science ®Google Scholar
• Watanabe M, Kawano K, Toma K, et al. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. J Control Release 2008;127:231–8
   PubMed Web of Science ®Google Scholar
• Patankar N, Waterhouse D. Nano-particulate drug delivery systems for camptothecins. Cancer Therapy 2012;8:90–104
   Google Scholar
• Huang ZR, Hua SC, Yang YL, Fang JY. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin 2008;29:1094–102
   PubMed Web of Science ®Google Scholar
• Takimoto CH, Wright J, Arbuck SG. Clinical applications of the camptothecins. Biochim Biophys Acta 1998;1400:107–19
   PubMed Web of Science ®Google Scholar
• Hatefi A, Amsden B. Camptothecin delivery methods. Pharm Res 2002;19:1389–99
   PubMed Web of Science ®Google Scholar
• Mason TG, Wilking JN, Meleson K, et al. Nanoemulsions: formation, structure, and physical properties. J Phys Condens Matter 2006;18:R635
   Web of Science ®Google Scholar
• Chen H, Khemtong C, Yang X, et al. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today 2011;16:354–60
   PubMed Web of Science ®Google Scholar
• Bansal SS, Goel M, Aqil F, et al. Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res (Phila) 2011;4:1158–71
   PubMed Web of Science ®Google Scholar
• Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998;95:4607–12
   PubMed Web of Science ®Google Scholar
• Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 2009;6:928–39
   PubMed Web of Science ®Google Scholar
• Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 2007;8:E12–17
   PubMed Web of Science ®Google Scholar
• Thapa D, Palkar VR, Kurup MB, Malik SK. Properties of magnetite nanoparticles synthesized through a novel chemical route. Mater Lett 2004;58:2692–4
   Web of Science ®Google Scholar
• Yang X, Hu Z, Chan SY, et al. Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat. J Chromatogr B 2005;821:221–8
   PubMed Web of Science ®Google Scholar
• Zhai Y, Guo S, Liu C, et al. Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloid Surf A 2013;429:24–30
   Web of Science ®Google Scholar
• Katas H, Hussain Z, Ling TC. Chitosan nanoparticles as a percutaneous drug delivery system for hydrocortisone. J Nanomater 2012;2012:1–11
   Google Scholar
• Amin K, Dannenfelser RM. In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci 2006;95:1173–6
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184–91
   PubMed Web of Science ®Google Scholar
• Conover CD, Greenwald RB, Pendri A, et al. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker. Cancer Chemother Pharmacol 1998;42:407–14
   PubMed Web of Science ®Google Scholar
• Martins SM, Wendling T, Gonçalves VM, et al. Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles. J Chromatogr B 2012;880:100–7
   PubMed Web of Science ®Google Scholar
• Sarker DK. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2005;2:297–310
   PubMedGoogle Scholar
• Wang L, Dong J, Chen J, et al. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 2009;330:443–8
   PubMed Web of Science ®Google Scholar
• Yalkowsky SH, Krzyzaniak JF, Ward GH. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci 1998;87:787–96
   PubMed Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003;36:R167–81
   Web of Science ®Google Scholar
• Werbovetz KA, Bhattacharjee AK, Brendle JJ, Scovill JP. Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity. Bioorg Med Chem 2000;8:1741–7
   PubMed Web of Science ®Google Scholar
• Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 2004;56:827–40
   PubMed Web of Science ®Google Scholar
• Lee BS, Nalla AK, Stock IR, et al. Oxidative stimuli-responsive nanoprodrug of camptothecin kills glioblastoma cells. Bioorg Med Chem Lett 2010;20:5262–8
   PubMed Web of Science ®Google Scholar
• Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004;21:201–30
   PubMed Web of Science ®Google Scholar
• Meyer BK, Ni A, Hu B, Shi L. Antimicrobial preservative use in parenteral products: past and present. J Pharm Sci 2007;96:3155–67
   PubMed Web of Science ®Google Scholar
• Simamora P, Alvarez JM, Yalkowsky SH. Solubilization of rapamycin. Int J Pharm 2001;213:25–9
   PubMed Web of Science ®Google Scholar
• Fabiano V, Mameli C, Zuccotti GV. Paediatric pharmacology: remember the excipients. Pharmacol Res 2011;63:362–5
   PubMed Web of Science ®Google Scholar
• Cinelli MA, Morrell A, Dexheimer TS, et al. Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors. J Med Chem 2008;51:4609–19
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm 2007;4:465–74
   PubMed Web of Science ®Google Scholar
• Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm 2000;198:7–27
   PubMed Web of Science ®Google Scholar
• Benita S, Levy MY. Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. J Pharm Sci 1993;2:1069–79
   Web of Science ®Google Scholar
• He W, Tan Y, Tian Z, et al. Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in-vitro characterization, and pharmacokinetics in rats. Int J Nanomedicine 2011;6:521–33
   PubMed Web of Science ®Google Scholar
• Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci 2004;108–109:303–18
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Schmidt S, Müller RH, Benita S. In-vitro adsorption of plasma proteins onto the surface (charges) modified-submicron emulsions for intravenous administration. Eur J Pharm Biopharm 2005;59:1–7
   PubMed Web of Science ®Google Scholar
• Mu L, Seow PH. Application of TPGS in polymeric nanoparticulate drug delivery system. Colloids Surf B Biointerfaces 2006;47:90–7
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Trubetskoy VS. Which polymers can make nanoparticulate drug carriers long-circulating. Adv Drug Deliv Rev 1995;16:141–55
   Web of Science ®Google Scholar
• Bahadur D, Giri J. Biomaterials and magnetism. Sadhana 2003;28:639–56
   Web of Science ®Google Scholar
• Hu FX, Neoh KG, Kang ET. Synthesis and in-vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 2006;27:5725–33
   PubMed Web of Science ®Google Scholar
• Krzynzaniak JF, Alvarez Nunez FA, Raymond DM, Yalkowsky SH. Lysis of human red blood cells. 4. Comparison of in-vitro and in-vivo hemolysis data. J Pharm Sci 1997;86:1215–17
   PubMed Web of Science ®Google Scholar
• Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and D-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 2005;306:142–9
   PubMed Web of Science ®Google Scholar